Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hormone Replacement Therapy
Regulatory
FDA rolls back warning labels on HRT products for menopause
Pharmas are expected to update and reprint product labeling to remove references to risks of cardiovascular disease, breast cancer and dementia.
Anastassia Gliadkovskaya
Nov 10, 2025 1:33pm
SCOTUS upholds Tennessee ban on transgender care for youth
Jun 18, 2025 11:55am
Carrot Fertility introduces hormone replacement therapy coverage
Mar 29, 2023 4:30pm
Evernow lands $28.5M series A for virtual menopause treatments
Apr 6, 2022 10:00am
